Community Investing Ideas

Global Weekly Picks

AU$0.26
59.6% undervalued intrinsic discount
LeoChivo Fair Value
Revenue growth
0.69% p.a.
Profit Margin
7.3%
Future PE
12.02x
Share price in 2029
AU$0.14
US$112.55
15.6% undervalued intrinsic discount
bucailei Fair Value
Revenue growth
5.25% p.a.
Profit Margin
21.98%
Future PE
20.98x
Share price in 2027
US$132.99
PPGN logo
PolyPeptide Group

Biotech longerterm bet

211011 Draupnir noch ein Anteil von rund 55,5% an Polypeptide. Der «Free Float» an der Börse SIX erhöht sich dadurch gleichzeitig von 40,0 auf rund 44,5%.Read more

View narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CHF 33.1
28.4% undervalued intrinsic discount
PKU Fair Value
Revenue growth
11.03% p.a.
Profit Margin
13.61%
Future PE
18.34x
Share price in 2029
CHF 41.08
US$486.86
36.0% undervalued intrinsic discount
Revenue growth
9.81% p.a.
Profit Margin
4.05%
Future PE
25x
Share price in 2026
US$537.61
US$86
95.0% undervalued intrinsic discount
RockeTeller Fair Value
Revenue growth
170.05% p.a.
Profit Margin
3.07%
Future PE
99.57x
Share price in 2029
US$102.22
US$705.22
55.7% undervalued intrinsic discount
Bailey Fair Value
Revenue growth
16.7% p.a.
Profit Margin
28%
Future PE
35x
Share price in 2028
US$978.74
US$38
378.6% overvalued intrinsic discount
Goran_Damchevski Fair Value
Revenue growth
21% p.a.
Profit Margin
17.3%
Future PE
28x
Share price in 2029
US$48.39
US$174.08
52.9% overvalued intrinsic discount
iStock Fair Value
Revenue growth
-1.01% p.a.
Profit Margin
26.44%
Future PE
33.73x
Share price in 2029
US$247.17